Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7999)
All Articles published online
|
Publishing Process of This Article
|
May 15, 2021 (publication date) through Mar 25, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ríos-Ríos WJ, Sosa-Luis SA, Torres-Aguilar H. Current advances in using tolerogenic dendritic cells as a therapeutic alternative in the treatment of type 1 diabetes. World J Diabetes 2021; 12(5): 603-615 [PMID: 33995848 DOI: 10.4239/wjd.v12.i5.603] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v12/i5/603.htm |
| Number | Citing Articles |
| 1 |
Caitlin N. Suire, Mangesh D. Hade. Extracellular Vesicles in Type 1 Diabetes: A Versatile Tool. Bioengineering 2022; 9(3): 105 doi: 10.3390/bioengineering9030105
|
| 2 |
Melanie Rodacki, Karina Ribeiro Silva, Debora Batista Araujo, Joana R. Dantas, Maria Eduarda Nascimento Ramos, Lenita Zajdenverg, Leandra Santos Baptista. Immunomodulatory agents and cell therapy for patients with type 1 diabetes. Archives of Endocrinology and Metabolism 2024; 68 doi: 10.20945/2359-4292-2024-0233
|
| 3 |
Shiva Alipour, Tohid Kazemi, Mohammad Reza Sadeghi, Javad Ahmadian Heris, Javad Masoumi, Bahar Naseri, Elham Baghbani, Sepideh Sohrabi, Behzad Baradaran. Glyburide-treated human monocyte-derived dendritic cells loaded with insulin represent tolerogenic features with anti-inflammatory responses and modulate autologous T cell responses in vitro. International Immunopharmacology 2024; 126: 111230 doi: 10.1016/j.intimp.2023.111230
|
| 4 |
Irina Buckle, Josephine M. Forbes. Type 1 Diabetes in 2023 - From Real Practice to Open Questions. 2023; doi: 10.5772/intechopen.108528
|
| 5 |
Nélio A.J. Oliveira, Handan Sevim. Dendritic Cell Differentiation from Human Induced Pluripotent Stem Cells: Challenges and Progress. Stem Cells and Development 2022; 31(9-10): 207 doi: 10.1089/scd.2021.0305
|
| 6 |
Liu YANG, Xuejiao ZHANG, Qing LIU, Yan WEN, Qing WANG. Update on the ZNT8 epitope and its role in the pathogenesis of type 1 diabetes. Minerva Endocrinology 2023; 48(4) doi: 10.23736/S2724-6507.22.03723-X
|
| 7 |
Bahar Naseri, Shiva Alipour, Javad Masoumi, Amirhossein Hatami‐Sadr, Edris Vaysi, Nima Hemmat, Nazila Alizadeh, Behzad Baradaran. RAD001-mediated mTOR targeting in human monocyte-derived dendritic cells shifts them toward an immunogenic phenotype. Immunologic Research 2025; 73(1) doi: 10.1007/s12026-024-09572-8
|
| 8 |
Khalid Siddiqui, Shaik Sarfaraz Nawaz. Exploration of Immune Targets for Type 1 Diabetes and Latent Autoimmune Disease Immunotherapy. ImmunoTargets and Therapy 2023; : 91 doi: 10.2147/ITT.S417917
|
| 9 |
Nick Giannoukakis. Tolerogenic dendritic cells in type 1 diabetes: no longer a concept. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1212641
|
| 10 |
William de Jesús Ríos-Ríos, Honorio Torres-Aguilar. Graft-Versus-Host Disease. Methods in Molecular Biology 2025; 2907: 287 doi: 10.1007/978-1-0716-4430-0_13
|